文献速递细菌感染、耐药与抗菌药物

脂质运载蛋白2作为细菌性脑膜炎潜在生物标志物的价值

Value of lipocalin 2 as a potential biomarker for bacterial meningitis.
PubMed 文献 · Clin Microbiol Infect · 2020-07-11

该研究通过液相色谱串联质谱在45例脑脊液样本中发现脂质运载蛋白2(LCN2)可能是细菌性脑膜炎(BM)的生物标志物,并在越南364例连续成人中枢神经系统感染队列中验证。LCN2区分BM与其他中枢神经系统感染的灵敏度为0.88(95%CI 0.77-0.94),特异度为0.91(95%CI 0.88-0.94),诊断比值比73.8(95%CI 31.8-171.4),优于常规脑脊液标志物,联合常规标志物曲线下面积达0.96(95%CI 0.93-0.99)。

要点

  • LCN2区分细菌性脑膜炎与其他中枢神经系统感染灵敏度0.88、特异度0.91。
  • LCN2诊断性能优于脑脊液白细胞、葡萄糖、蛋白和乳酸。
  • LCN2联合常规脑脊液标志物诊断BM的AUC达0.96。

核心结论

  • LCN2是区分细菌性脑膜炎与广谱其他中枢神经系统感染的敏感且特异的生物标志物。
  • 需前瞻性研究评估LCN2在中枢神经系统感染诊断和管理中的效用。

研究设计与样本

  • 发现阶段:对45例有或无中枢神经系统感染的成人脑脊液样本进行液相色谱串联质谱分析。
  • 验证阶段:在越南一家转诊医院364例连续治疗的成人中枢神经系统感染独立队列中验证候选标志物诊断性能。

主要发现

  • 发现队列中鉴定出LCN2为除结核性脑膜炎外的细菌性脑膜炎潜在生物标志物。
  • 验证队列中LCN2区分BM与其他中枢神经系统感染(包括结核性脑膜炎、隐球菌性脑膜炎和病毒/抗体介导脑炎)的灵敏度为0.88(95%CI 0.77-0.94),特异度为0.91(95%CI 0.88-0.94),诊断比值比73.8(95%CI 31.8-171.4)。
  • LCN2优于全球常规使用的其他脑脊液标志物(白细胞、葡萄糖、蛋白和乳酸)。
  • LCN2联合脑脊液白细胞、葡萄糖、蛋白和乳酸对BM的诊断性能最高,AUC为0.96(95%CI 0.93-0.99)。

关键数值与推荐

  • 细菌性脑膜炎诊断标志物LCN2的灵敏度0.88(95%CI 0.77-0.94),特异度0.91(95%CI 0.88-0.94),诊断比值比73.8(95%CI 31.8-171.4)。
  • LCN2联合常规脑脊液标志物诊断BM的AUC为0.96(95%CI 0.93-0.99)。

临床怎么用

  • LCN2可作为快速鉴别细菌性脑膜炎与其他中枢神经系统感染的脑脊液生物标志物候选。
  • 联合LCN2与常规脑脊液标志物可能提高细菌性脑膜炎的诊断准确性。
  • 目前尚需前瞻性研究验证后方可用于临床诊断和管理决策。

局限性

  • 需要前瞻性研究评估LCN2在中枢神经系统感染诊断和管理中的效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Central nervous system (CNS) infections are common causes of morbidity and mortality worldwide. We aimed to discover protein biomarkers that could rapidly and accurately identify the likely cause of the infections, essential for clinical management and improving outcome. METHODS: We applied liquid chromatography tandem mass spectrometry on 45 cerebrospinal fluid (CSF) samples from a cohort of adults with and without CNS infections to discover potential diagnostic biomarkers. We then validated the diagnostic performance of a selected biomarker candidate in an independent cohort of 364 consecutively treated adults with CNS infections admitted to a referral hospital in Vietnam. RESULTS: In the discovery cohort, we identified lipocalin 2 (LCN2) as a potential biomarker of bacterial meningitis (BM) other than tuberculous meningitis. The analysis of the validation cohort showed that LCN2 could discriminate BM from other CNS infections (including tuberculous meningitis, cryptococcal meningitis and virus/antibody-mediated encephalitis), with sensitivity of 0.88 (95% confident interval (CI), 0.77-0.94), specificity of 0.91 (95% CI, 0.88-0.94) and diagnostic odds ratio of 73.8 (95% CI, 31.8-171.4). LCN2 outperformed other CSF markers (leukocytes, glucose, protein and lactate) commonly used in routine care worldwide. The combination of LCN2, CSF leukocytes, glucose, protein and lactate resulted in the highest diagnostic performance for BM (area under the receiver operating characteristics curve, 0.96; 95% CI, 0.93-0.99). Data are available via ProteomeXchange with identifier PXD020510. CONCLUSIONS: LCN2 is a sensitive and specific biomarker for discriminating BM from a broad spectrum of other CNS infections. A prospective study is needed to assess the diagnostic utility of LCN2 in the diagnosis and management of CNS infections.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Thanh TT, Casals-Pascual C, Ny NTH, et al. Value of lipocalin 2 as a potential biomarker for bacterial meningitis. Clin Microbiol Infect. 2020. PMID: 32659386. doi:10.1016/j.cmi.2020.07.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。